Silk Road Medical, Inc
SILK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $476 | $1,891 | $1,476 | $2,076 |
| - Cash | $20 | $55 | $110 | $69 |
| + Debt | $85 | $76 | $49 | $49 |
| Enterprise Value | $541 | $1,912 | $1,414 | $2,055 |
| Revenue | $177 | $139 | $101 | $75 |
| % Growth | 27.8% | 36.6% | 34.9% | – |
| Gross Profit | $127 | $101 | $76 | $54 |
| % Margin | 71.7% | 72.7% | 74.9% | 71.7% |
| EBITDA | -$45 | -$47 | -$46 | -$41 |
| % Margin | -25.4% | -33.7% | -44.9% | -55.1% |
| Net Income | -$56 | -$58 | -$50 | -$50 |
| % Margin | -31.5% | -41.8% | -49.7% | -67% |
| EPS Diluted | -1.44 | -1.62 | -1.45 | -1.53 |
| % Growth | 11.1% | -11.7% | 5.2% | – |
| Operating Cash Flow | -$32 | -$33 | -$39 | -$42 |
| Capital Expenditures | -$2 | -$5 | -$5 | -$1 |
| Free Cash Flow | -$34 | -$38 | -$44 | -$43 |